Centogene N.V. CNTG
$ 0.33
-6.23%
Annual report 2023
added 12-21-2024
Country |
Germany |
IPO year |
2019 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Prof. Arndt Rolfs |
Employees in the company |
440 |
Shares |
- |
Market Cap[1] |
$ 30.6 M |
EBITDA (LTM) |
$ -53.4 M |
P/E (LTM) |
-0.58 |
P/S (LTM) |
- |
EPS (LTM) |
-1.83 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.